Soligenix Shares Are Trading Higher After the Company Announced That It Received Notice of Intent to Grant Additional Patents Based on Its Patent Application Titled "Compositions and Methods of Manufacturing Trivalent Filovirus Vaccines" in the United Kingdom and South Africa, With Other International Jurisdictions Pending
Soligenix的股价走高，此前该公司宣布收到意向授予额外专利的通知，该专利基于其在英国和南非的名为 “三价丝状病毒疫苗的制造成分和方法” 的专利申请，其他国际司法管辖区正在审理中